X-ray fluorescence analysis characterises pharmaceutical elemental composition enabling contaminant detection. Primary X-ray excitation produces fluorescence. Spectral analysis identifies elements present. Quantitation determines elemental concentrations. Non-destructive analysis preserves samples.
Regulatory applications include heavy metal monitoring. Quality control detects elemental contamination. Post-approval monitoring confirms purity. Emerging technologies improve sensitivity. Rapid analysis expedites assessment.
General Biopharmaceutical Concepts
X-Ray Fluorescence Analysis
X-ray fluorescence analysis identifies and quantifies elemental composition by measuring characteristic X-rays emitted following excitation.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →